Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial

Ítems similars

• An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial
  per: Hill, Louise F., et al.
  Publicat: (2020)
• Pharmacokinetics of Penicillin G in Very-Low-Birth-Weight Neonates
  per: Metsvaht, Tuuli, et al.
  Publicat: (2007)
• Clinical parameters predicting failure of empirical antibacterial therapy in early onset neonatal sepsis, identified by classification and regression tree analysis
  per: Metsvaht, Tuuli, et al.
  Publicat: (2009)
• The development of gut microbiota in critically ill extremely low birth weight infants assessed with 16S rRNA gene based sequencing
  per: Drell, Tiina, et al.
  Publicat: (2014)
• Short versus Long Infusion of Meropenem in Very-Low-Birth-Weight Neonates
  per: Padari, Helgi, et al.
  Publicat: (2012)